Product image of Mestinon Retard (Pyridostigmine Bromide) supplied by GNH India

Mestinon Retard

Active Ingredient:
Pyridostigmine Bromide
Origin:
EU

Mestinon Retard (Pyridostigmine Bromide)

Pyridostigmine bromide, the active ingredient in Mestinon Retard, is a cholinesterase inhibitor presented as an extended‑release tablet for oral use. It treats myasthenia gravis by improving neuromuscular transmission in affected patients and is classified within the anticholinesterase therapeutic class.

GNH India supplies Mestinon Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for clinical and institutional needs across Europe, Asia and the Americas.

Manufacturer / TM Owner

Viatris Healthcare Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mestinon Retard, a cholinesterase inhibitor, is indicated for conditions involving impaired neuromuscular transmission.

  • Generalized myasthenia gravis: improves overall muscle strength and reduces fatigue.
  • Ocular myasthenia gravis: alleviates eye‑muscle weakness and diplopia.
  • Myasthenic crisis prevention: helps maintain adequate neuromuscular function during periods of increased stress or infection.

How It Works

  • Pyridostigmine bromide reversibly inhibits acetylcholinesterase at the neuromuscular junction, preventing the breakdown of acetylcholine. The resulting increase in synaptic acetylcholine enhances stimulation of nicotinic receptors on skeletal muscle, thereby improving muscle contraction and reducing the weakness characteristic of myasthenia gravis.

Side Effects

Adverse reactions may occur with pyridostigmine bromide therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: increased bowel movements.
  • Abdominal cramps: discomfort in the stomach area.
  • Excessive salivation: drooling or increased oral secretions.
  • Muscle cramps: involuntary tightening of muscles.
  • Increased urinary frequency: more frequent urination.

Serious or Rare Side Effects

  • Cholinergic crisis: severe muscle weakness, respiratory failure.
  • Bradycardia: markedly slow heart rate.
  • Bronchospasm: narrowing of airways causing breathing difficulty.
  • Allergic reactions: rash, itching, or anaphylaxis.
  • Seizures: rare neurologic events.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Renal impairment: adjust dose based on renal function.
  • Asthma or COPD: monitor for bronchospasm.
  • Concomitant anticholinergics: avoid antagonistic effects.
  • Sudden discontinuation: taper to prevent cholinergic rebound.
  • Pregnancy and lactation: safety unknown; use only if benefit outweighs risk.
  • Store at ambient temperature (below 25 °C): keep in the original pack, protect from moisture.

Avoid Interactions

Pyridostigmine bromide can interact with several medicines.

Major Interactions (Avoid)

  • Anticholinergic drugs: may reduce therapeutic effect.
  • Beta‑blockers: can exacerbate bradycardia.
  • Magnesium‑containing antacids: diminish absorption.

Moderate Interactions (Monitor Closely)

  • Other cholinesterase inhibitors: risk of cumulative cholinergic toxicity.
  • Neuromuscular blocking agents: may potentiate muscle weakness.
  • Diuretics: monitor electrolyte balance.

Frequently Asked Questions

Mestinon Retard contains pyridostigmine bromide and is used to treat myasthenia gravis, a disorder that causes muscle weakness due to impaired neuromuscular transmission.

The drug reversibly inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine, thereby increasing acetylcholine levels at the neuromuscular junction and enhancing muscle contraction.

The dose is individualized; a qualified prescriber determines the appropriate amount and dosing schedule based on the patient’s condition, response, and renal function.

Safety data are limited; the product should be used only if the potential benefit justifies the potential risk to the fetus or infant, and decisions should be made by the treating physician.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mestinon Retard offers an extended‑release formulation that provides more stable plasma concentrations compared with immediate‑release pyridostigmine, potentially reducing dosing frequency and improving patient adherence.

Store the tablets at ambient temperature below 25 °C, in the original container, protected from moisture and direct sunlight to maintain product stability.

The medication is taken orally, usually with water, and can be taken with or without food as directed by the prescriber.

The most serious risks include cholinergic crisis, severe bradycardia, bronchospasm, and rare allergic reactions such as anaphylaxis; patients should seek immediate medical attention if these occur.

Patients with known hypersensitivity to pyridostigmine bromide or any excipients, and those with uncontrolled asthma or severe cardiac conduction disorders should avoid using this medication unless specifically advised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.